title: Biomarkers in colorectal cancer.
abstract: Systemic therapies available for treatment of colorectal cancer have increased in recent years, leading to improved clinical outcomes. However, a significant proportion of patients fail to derive meaningful benefits, whereas others suffer from unacceptable toxicities. Therefore, not only does the search for novel and effective anticancer agents continue, there is also a pressing need to optimise the use of all treatments in the therapeutic armamentarium. In addition to knowledge gleaned from well-designed and relevant clinical trials, increasing effort is being invested into biomarkers. The identification and implementation of validated biomarkers has the potential to further our understanding of the biology of colorectal cancer and also to greatly improve the efficiency with which cancer treatments are administered.
authors.affiliation: Medical Oncology Department, Vall d'Hebron University Hospital and Vall d'Hebron Institute of Oncology, Barcelona, Spain.
authors.forename: B
authors.initials: B
authors.lastname: Markman
authors.forename: V
authors.initials: V
authors.lastname: Rodríguez-Freixinos
authors.forename: J
authors.initials: J
authors.lastname: Tabernero
mesh_terms: D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology; D014408:Biomarkers, Tumor; D002986:Clinical Trials as Topic; D015179:Colorectal Neoplasms / Q000175:diagnosis* / Q000188:drug therapy* / Q000235:genetics*; D016503:Drug Delivery Systems / Q000379:methods; D055808:Drug Discovery / Q000379:methods; D006801:Humans
chemical_list: D000970:Antineoplastic Agents; D014408:Biomarkers, Tumor
references.citation: Anticancer Res. 2007 Jan-Feb;27(1B):627-33
references.pmid: 17348452
references.citation: J Clin Invest. 1996 Aug 1;98(3):610-5
references.pmid: 8698850
references.citation: J Clin Oncol. 2009 Apr 10;27(11):1814-21
references.pmid: 19273709
references.citation: Ann Oncol. 2008 May;19(5):915-9
references.pmid: 18245778
references.citation: J Clin Oncol. 2007 Aug 1;25(22):3230-7
references.pmid: 17664471
references.citation: J Clin Oncol. 2004 Apr 15;22(8):1382-8
references.pmid: 15007088
references.citation: Oncology. 2006;70(5):366-77
references.pmid: 17179731
references.citation: BMC Cancer. 2009 Sep 24;9:339
references.pmid: 19775480
references.citation: Ann Oncol. 2009 Jul;20(7):1223-9
references.pmid: 19282466
references.citation: Cancer Res. 1998 Nov 15;58(22):5248-57
references.pmid: 9823339
references.citation: J Clin Oncol. 2006 Nov 20;24(33):5313-27
references.pmid: 17060676
references.citation: J Clin Oncol. 2008 Dec 10;26(35):5705-12
references.pmid: 19001320
references.citation: Ann Oncol. 2010 Apr;21(4):772-780
references.pmid: 19833818
references.citation: J Clin Oncol. 2004 Feb 1;22(3):529-36
references.pmid: 14752076
references.citation: Cancer Res. 2008 Mar 15;68(6):1953-61
references.pmid: 18339877
references.citation: J Clin Oncol. 2005 Jan 20;23(3):609-18
references.pmid: 15659508
references.citation: J Clin Oncol. 2009 Mar 1;27(7):1122-9
references.pmid: 19164213
references.citation: Clin Pharmacol Ther. 2001 Mar;69(3):89-95
references.pmid: 11240971
references.citation: N Engl J Med. 2008 Oct 23;359(17):1757-65
references.pmid: 18946061
references.citation: Pharmacogenomics J. 2002;2(1):43-7
references.pmid: 11990381
references.citation: Br J Cancer. 2010 Jan 5;102(1):162-4
references.pmid: 19953097
references.citation: Carcinogenesis. 2004 Apr;25(4):527-33
references.pmid: 14688025
references.citation: J Clin Oncol. 2004 Apr 1;22(7):1201-8
references.pmid: 14993230
references.citation: Clin Cancer Res. 2009 May 1;15(9):3184-8
references.pmid: 19366826
references.citation: Cancer Res. 2009 Mar 1;69(5):1851-7
references.pmid: 19223544
references.citation: Nat Rev Mol Cell Biol. 2001 Feb;2(2):127-37
references.pmid: 11252954
references.citation: J Clin Oncol. 2008 Apr 1;26(10):1626-34
references.pmid: 18316791
references.citation: J Clin Oncol. 2001 Dec 1;19(23):4298-304
references.pmid: 11731512
references.citation: N Engl J Med. 2007 Nov 15;357(20):2040-8
references.pmid: 18003960
references.citation: Br J Cancer. 2008 Oct 7;99(7):1050-5
references.pmid: 18797464
references.citation: J Clin Oncol. 2008 Jun 1;26(16):2690-8
references.pmid: 18509181
references.citation: J Clin Oncol. 2009 Dec 10;27(35):5924-30
references.pmid: 19884556
references.citation: J Clin Oncol. 2007 Mar 1;25(7):767-72
references.pmid: 17228023
references.citation: Br J Cancer. 2005 Feb 14;92(3):434-44
references.pmid: 15668707
references.citation: N Engl J Med. 2004 Dec 30;351(27):2883
references.pmid: 15625347
references.citation: J Surg Res. 2005 Apr;124(2):169-74
references.pmid: 15820244
references.citation: Br J Cancer. 2001 Sep 1;85(5):692-6
references.pmid: 11531254
references.citation: Proc Natl Acad Sci U S A. 2008 Feb 19;105(7):2652-7
references.pmid: 18268322
references.citation: J Clin Oncol. 2009 Oct 20;27(30):5068-74
references.pmid: 19738126
references.citation: Clin Cancer Res. 2000 Apr;6(4):1322-7
references.pmid: 10778957
references.citation: J Clin Oncol. 2009 Apr 20;27(12):2091-6
references.pmid: 19188670
references.citation: Int J Cancer. 1997 Jan 27;70(3):335-40
references.pmid: 9033637
references.citation: N Engl J Med. 1996 Dec 5;335(23):1727-32
references.pmid: 8929264
references.citation: J Natl Cancer Inst. 1998 May 6;90(9):675-84
references.pmid: 9586664
references.citation: J Clin Oncol. 2007 Aug 1;25(22):3238-45
references.pmid: 17664472
references.citation: N Engl J Med. 2009 Apr 2;360(14):1408-17
references.pmid: 19339720
references.citation: N Engl J Med. 2003 Jul 17;349(3):247-57
references.pmid: 12867608
references.citation: J Clin Oncol. 2008 Jul 1;26(19):3213-21
references.pmid: 18591556
references.citation: Ann Oncol. 2009 May;20(5):879-84
references.pmid: 19179548
references.citation: N Engl J Med. 1994 Jul 28;331(4):213-21
references.pmid: 8015568
references.citation: Lancet Oncol. 2005 May;6(5):279-86
references.pmid: 15863375
references.citation: N Engl J Med. 2004 Jul 22;351(4):337-45
references.pmid: 15269313
references.citation: J Clin Oncol. 2005 Mar 20;23(9):1803-10
references.pmid: 15677699
references.citation: J Clin Oncol. 2009 Feb 10;27(5):663-71
references.pmid: 19114683
references.citation: J Clin Oncol. 2003 Jan 15;21(2):241-50
references.pmid: 12525515
references.citation: Clin Cancer Res. 2009 Dec 1;15(23):7322-9
references.pmid: 19934290